Faculty & Staff Detail
Jennifer L. Mathews, Ph.D.
Title: Associate Professor
Office: WEGPHR 339
Phone: (585) 899-3805
Education: Ph.D., University of Rochester School of Medicine and Dentistry
M.S., University of Rochester School of Medicine and Dentistry
M.A., University of Northern Colorado
B.A., State University of New York at Potsdam
Dr. Mathews received her Ph.D. in Pharmacology from the University of Rochester School of Medicine and Dentistry. She began her tenure at St. John Fisher College in 2007. Dr. Mathews teaches in the Department of Pharmaceutical Sciences and her courses include: Systems Pharmacology I-V, Diversity, and Substances of Abuse.
Dr. Mathews’ research is focused on the scholarship of teaching and learning. Research projects include novel in class exercises, community outreach and models of assessment. Of particular interest are topics related to opioid pharmacology and cultural competency. Dr. Mathews has mentored pharmacy and undergraduate Science Scholar students.
In 2010, Dr. Mathews was recognized by St. John Fisher College (Diversity Innovations Award) and the American Association of Colleges of Pharmacy (Innovations in Teaching Award, Honorable Mention) for her implementation of Deaf Strong Hospital at the Wegmans School of Pharmacy. This role-reversal program was designed to teach the first-year students about techniques for overcoming communication barriers as well as some of the specific challenges in communicating with deaf or hard-of-hearing patients. Dr. Mathews served as the faculty mentor for Salia Farrokh (2009) and Rosemary Garbowski (2011), recipients of the AACP/Wal-Mart Scholarship, which encourages pharmacy students to consider a career in academia. In 2007, only one year after joining the faculty at SJFC, Dr. Mathews was voted Teacher of the Year by the student body of the Wegmans School of Pharmacy.
Dr. Mathews has also been recognized by the scientific community, receiving travel awards from the International Narcotics Research Conference and the National Institute of Drug Abuse. While working on her M.A. degree at the University of Northern Colorado, she received the Dean’s Citation for Outstanding Thesis and a Grant in Aid of Research from the Sigma Xi Honor Society. Dr. Mathews is active in several scientific and educational organizations including:
- The American Society of Health-Systems Pharmacists
- The American Association of Colleges of Pharmacy
- The College on the Problems of Drug Dependence
Parkhill AL, Gainsburg J, Fearing S, and Mathews JL (2011) The need for transgender health content in the pharmacy curriculum. Innovations in Pharmacy 2(4): article 58 (4 pages).
Mathews JL, Parkhill, AL, Schlehofer DA, Starr MJ, and Barnett S (2011) Role-Reversal Exercise with Deaf Strong Hospital to Teach Communication Competency and Cultural Awareness. AJPE 75(3):1-10. [PMID: 19020012]
Lavigne JE, Mathews JL, Knox KL (2010) The pharmacology and epidemiology of post-market surveillance for suicide: the case of gabapentin. JPHSR 1:47-51.
Parkhill AL, Mathews JL, and Blanchard NR (2009) “Pediatric and adolescent sports-related injuries and ailments.” US Pharmacist 34 (3).
Mathews JL, Smrcka AV, and Bidlack JM (2008) “A novel Gßg inhibitor selectively modulates µ-opioid-dependent antinociception and attenuates acute morphine-induced antinociceptive tolerance and dependence”. J Neurosci 28(47):12183-12189. [PMID: 19020012]
Mathews JL, Fulton BS, Negus SS, Neumeyer JL, and Bidlack JM (2008) “In vivo Characterization of (-)(-)MCL-144 and (+)(-)MCL-193: Isomeric, bivalent ligands with mu/kappa agonist properties.” Neurochem Res 33 (10):2142-2150. [PMID: 18528756]
Bonacci TM, Mathews JL, Yuan C, Lehmann D, Malik S, Wu D, Font JL, Bidlack JM, and Smrcka AV (2006) “Differential targeting of Gbg-subunit signaling with small molecules.” Science. 312:443-446. [PMID: 16627746]
Mathews JL and Bidlack JM (2008) “The chemistry and pharmacology of mu opioid antagonists,” in Opioid Receptors and Antagonist: From Bench to Clinic (Dean RL, Bilsky EJ, and Negus SS eds) pp 83-97, Springer/Humana Press, New York.
Mathews JL, Peng X, Xiong W, Zhang A, Negus SS, Neumeyer JL, and Bidlack JM (2005) “Characterization of a novel bivalent morphinan possessing k agonist and m agonist/antagonist properties.” J Pharmacol Exp Ther 315:821-827. [PMID: 16076937]
Mathews JL, Bartlett JL, Ananthan S, and Bilsky EJ (2001) “In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid µ-agonist/d-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence”. J Pharmacol Exp Ther 297:597-605.
Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Mathews JL, Davis P, Xu H, Dersch CM, Bilsky EJ Porreca F, and Rothman RB (1999) “Synthesis, opioid receptor binding, and biological activities of naltrexone derived pyrido-and pyrimidomorphinans.” J Med Chem 42:3527-3538.
Mathews JL, Dave C, Mohammad M, Cipriano G, Zhao F and Lowry B. Pharmacy-student outreach: bridging the gap from an inner-city high school to pharmacy school. American Association of Colleges of Pharmacy Meeting, Kissimmee, Florida, USA, July, 2012.
Souza JM, Parkhill AL, and Mathews JL. Course level curriculum map pilot program. American Association of Colleges of Pharmacy Meeting, Kissimmee, Florida, USA, July, 2012.
Utter CR, Bova RJ, Mathews JL, and Lull M. Individualized reflective learning through portfolio use in pharmacy school education. American Association of Colleges of Pharmacy Meeting, Kissimmee, Florida, USA, July, 2012.
Hutchinson DJ, Mathews JL, Souza JM, Corigliano A, Traina A, Juba K, and Lavigne JE. The crossroads of inter-professionalism: four avenues of collaboration at the Wegmans School of Pharmacy. American Association of Colleges of Pharmacy Meeting, Kissimmee, Florida, USA, July, 2012.
Jarbe RL, Piette NM, Dave C, Parkhill AL, Lull ME, Mathews JL. Implementing a substances of abuse program in the Rochester city school district. American Pharmacists Association Annual Meeting, New Orleans, Louisiana, USA, March, 2012.
Lull ME, Mathews JL, Jannetta EC, and Birnie CR. Student-led learning in the pharmaceutical sciences curriculum. American Association of Colleges of Pharmacy Meeting, San Antonio, Texas, USA, July, 2011.
Parkhill AL, Bradford S, Gainsburg J, Fearing S, and Mathews JL. Inclusion of a transgender panel discussion in a required diversity course. American Association of Colleges of Pharmacy Meeting, San Antonio, Texas, USA, July, 2011.
Mathews JL and Parkhill AL. Deaf Strong Hospital: A Role-Reversal Exercise Emphasizing Cultural Competency and Awareness. American Association of Colleges of Pharmacy Meeting, Seattle, Washington, USA, July, 2010.
Palesh O, Lavigne JE, Mustian K, Mathews JL, Heckler C, Peppone LJ, Janelsins M, Sprod LK, Morrow GR. Anxiolytic effect of Gabapentin in 321 breast cancer survivors: A URCC CCOP study. American Society of Clinical Oncology Meeting, Chicago, Illinois, USA, June, 2010.
Parkhill AL and Mathews JL. Evaluation of a multidisciplinary elective course on substance abuse. America Association of Colleges of Pharmacy Meeting, Boston, Massachusetts, USA, July, 2009.
Mathews JL, X. Peng, W. Xiong, A. Zhang, Neumeyer JL, and Bidlack JM. Characterization of novel bivalent ligands: an exploration of stereochemistry and the functional implications in vivo. International Narcotics Research Conference, St. Paul, Minnesota, USA, July, 2006.
Mathews JL, Neumeyer JL, and Bidlack JM. The bivalent ligand MCL-145 produces limited tolerance and attenuates morphine tolerance: a kappa mediated mechanism. International Narcotics Research Conference, Kyoto, Japan, July, 2004.
Mathews JL, Xiong W, Gu H, Neumeyer JL, and Bidlack JM. In vivo characterization of MCL-145: a morphinan derivative possessing mixed kappa agonist and mu agonist/antagonist properties. International Narcotics Research Conference, Perpignan, France, July, 2003.
Mathews JL, Bonney L, Porreca F, Ananthan S, and Bilsky EJ. Lack of antinociceptive tolerance with SoRI 9409, an opioid mu agonist/delta antagonist. South Western and Rocky Mountain Division of the American Association for the Advancement of Science Meeting, Santa Fe, New Mexico, USA, April, 1999.
Mathews, JL, Bonney, LE, Davis, P, Porreca, F, Ananthan, S and Bilsky, EJ. Pharmacological activities of naltrexone-derived pyrido- and pyrimidomorphinans. International Narcotics Research Conference, Saratoga, NY, USA, July 1999.
Mathews JL, Bonney L, Porreca F, Ananthan S, and Bilsky EJ. Characterization of the antinociceptive actions of SoRI 9409, an opioid mu agonist/delta antagonist. American Pain Society Meeting, Fort Lauderdale, Florida, USA, October, 1999.
Mathews JL, Bonney L, Porreca F, Ananthan S, and Bilsky EJ. Characterization of the antinociceptive actions of SoRI 9409, an opioid mu agonist/delta antagonist. Society for Neuroscience Annual Meeting, Miami Beach, Florida, USA, October, 1999.
Mathews JL. Implementing cultural competency in the pharmacy curriculum and embracing diversity in the healthcare system. American Association of Colleges of Pharmacy Meeting, Kissimmee, Florida, USA, July 2012.
Souza JM, Hutchinson DJ and Mathews JL. Considering a common coding system of ACPE standards to be used across campuses for curricular mapping and tracking student outcomes: a roundtable discussion. American Association of Colleges of Pharmacy Meeting, Kissimmee, Florida, USA, July 2012.
Mathews JL. The dopamine reward pathway and substances of abuse: it feels so good, how can it be wrong? The Rochester Area Society of Health-System Pharmacists Meeting, Rochester, New York, USA, February, 2009.
Mathews JL, Smrcka AV, and Bidlack JM. A novel role for the G-beta/gamma subunit in the attenuation of acute morphine antinociceptive tolerance and dependence. International Narcotics Research Conference, St. Paul, Minnesota, USA, July, 2006.
Mathews JL, Bonacci TM, Smrcka AV, and Bidlack JM. Attenuation of morphine tolerance through a novel Gbg mechanism. International Narcotics Research Conference, Annapolis, Maryland, USA, July, 2005.
Mathews JL, Neumeyer JL, and Bidlack JM. Kappa opioid receptor agonists attenuate acute morphine antinociceptive tolerance. College on the Problems of Drug Dependence Meeting, Orlando, Florida, USA, June, 2005.